Tilray reports positive results for cannabis chemo nausea treatment

Cannabis green leaves in medical plus sign emblem frame on white background.

Amax Photo

  • Tilray (NASDAQ:TLRY) reported positive results from a study of an oral cannabis extract in the treatment of chemotherapy-induced nausea and vomiting in patients who have not adequately responded to standard anti-nausea medications.
  • The study of 147 participants showed the cannabis

Leave a Reply

Your email address will not be published. Required fields are marked *